Open main menu
Search Ctrl + K
Free Trial
Loading...
Ibio, Inc.
Watch
Pharmaceutical Preparations
NYSE.IBIO
600 Madison Avenue, Suite 1601, New York, NY, 10022-1737
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Ownership
SC 13G
14 Nov 24
SC 13G/A
14 Nov 24
3
Banjak Marc
14 Aug 24
4
Brenner Martin
13 May 24
4
Duran Felipe
13 May 24
4
Duran Felipe
26 Apr 24
SC 13G/A
09 Apr 24
Proxies
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
10 Oct 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
26 Oct 23
PRE 14A
Preliminary Proxy Statement Not Yet Definitive.
16 Oct 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
02 Dec 22
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
26 Oct 22
DEFR14A
Definitive Revised Proxy Soliciting Materials (revised Material).
14 Jun 22
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
26 May 22
Prospectuses and Registrations
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
06 Aug 24
S-3/A
Amendment To The S-3 Registration Statement.
25 Jul 24
424B3
Prospectus Filed Pursuant To Rule 424(b)(3).
25 Apr 24
D
Notice Of An Exempt Offering Of Securities Under Regulation D.
04 Apr 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
10 Jan 24
424B3
Prospectus Filed Pursuant To Rule 424(b)(3).
06 Dec 23
S-1/A
Amendment To The S-1 Registration Statement.
30 Nov 23
News
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
12 Nov 24
8-K
Regulation Fd Disclosure, Financial Statements And Exhibits
23 Oct 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
20 Sep 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
26 Jul 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Amendments To The Registrant's Code Of Ethics, Or Waiver Of A Provision Of The Code Of Ethics, Financial Statements And Exhibits
09 Jul 24
8-K
Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
03 Jul 24
8-K
Termination Of A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Unregistered Sales Of Equity Securities, Regulation Fd Disclosure, Financial Statements And Exhibits
05 Jun 24
Financials
10-Q
Quarterly Filing
12 Nov 24
10-K/A
Fiscal Year 2024
24 Sep 24
10-K
Fiscal Year 2024
20 Sep 24
10-Q
Quarterly Filing
13 May 24
10-Q
Quarterly Filing
09 Feb 24
10-Q
Quarterly Filing
14 Nov 23
10-K
Fiscal Year 2023
27 Sep 23
Other
ARS
Scanned Paper Annual Report Submission.
10 Oct 24
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
06 Aug 24
S-3
Registration Statement Under The Securities Act.
03 Jul 24
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
24 Apr 24
S-3
Registration Statement Under The Securities Act.
16 Apr 24
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
04 Dec 23
CORRESP
Correspondence With The Sec.
30 Nov 23